Santo J. Costa

Director, NPS Pharmaceuticals (United States).

Companies

Aquestive Therapeutics, Inc.Board member Jul 24, 2018 to Jun 21, 2024¹
CytokineticsBoard member Nov 1, 2010 to May 16, 2024²
NPS Pharmaceuticals (United States)Board member Jan 19, 2006 to May 24, 2007³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cytokinetics CYTK20,600 shares⁴$1.3M at $62.76May 15, 2024
Aquestive Therapeutics, Inc. AQST17,327 shares⁵$65.1K at $3.75Jun 21, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

May 15, 2024Granted 5,600 shares of Cytokinetics⁴
May 10, 2023Granted 5,000 shares of Cytokinetics⁶
Sep 1, 2022Sold 15,000 shares at $52.79 of Cytokinetics⁷
Sep 1, 2022Exercised options 10,000 shares at $10.68 of Cytokinetics⁷
Sep 1, 2022Exercised options 5,000 shares at $9.45 of Cytokinetics⁷
May 10, 2022Granted 5,000 shares of Cytokinetics⁸
Mar 2, 2022Sold 10,000 shares at $37.35 of Cytokinetics⁹
Mar 2, 2022Exercised options 10,000 shares at $10.68 of Cytokinetics⁹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAquestive Therapeutics, Inc., Board member
2
SEC EDGARCytokinetics, Board member
3
SEC EDGARNPS Pharmaceuticals (United States), Board member
4
SEC EDGARCytokinetics shares after the filing of May 15, 2024
5
SEC EDGARAquestive Therapeutics, Inc. shares after the filing of Jun 21, 2024
6
SEC EDGARForm 4 filed May 18, 2023
7
SEC EDGARForm 4 filed Sep 1, 2022
8
SEC EDGARForm 4 filed May 11, 2022
9
SEC EDGARForm 4 filed Mar 2, 2022